CLINICAL_TRIALS
research
· 2016-04-06
Clinical Trial Update: Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating [Phase 1, Phase 2]
Summary
This clinical trial update describes a Phase 1/2 study evaluating individual boosting in non-small cell lung cancer using hypofractionation, intensity-modulated…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AHS Cancer Control Alberta | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: UNKNOWN